Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $617929.0.

  • Regenerative Medical Technology's Other Operating Expenses rose 5491.14% to $617929.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 4458.06%. This contributed to the annual value of $1.8 million for FY2024, which is 2768.94% up from last year.
  • As of Q3 2025, Regenerative Medical Technology's Other Operating Expenses stood at $617929.0, which was up 5491.14% from $598023.0 recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Other Operating Expenses registered a high of $2.8 million during Q4 2022, and its lowest value of -$10.7 million during Q3 2021.
  • For the 5-year period, Regenerative Medical Technology's Other Operating Expenses averaged around -$863779.1, with its median value being $394973.0 (2023).
  • Examining YoY changes over the last 5 years, Regenerative Medical Technology's Other Operating Expenses showed a top increase of 43947.01% in 2022 and a maximum decrease of 137117.77% in 2022.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Other Operating Expenses stood at -$818219.0 in 2021, then soared by 439.47% to $2.8 million in 2022, then plummeted by 89.12% to $302314.0 in 2023, then skyrocketed by 78.18% to $538650.0 in 2024, then grew by 14.72% to $617929.0 in 2025.
  • Its Other Operating Expenses stands at $617929.0 for Q3 2025, versus $598023.0 for Q2 2025 and $535939.0 for Q1 2025.